Chaddy - Keysight's investment has nothing to do with the stock being scarce as 'hens teeth' and everything to do with Keysight's confidence that EMV management and tech is well placed to succeed in AI-supported medical point of care imaging - a space that Keysight has a keen vested interest in. Given the use of its VNA in both Gen 1 and 2 devices, it will be particularly keen to see EMV succeed. Hence the substantial investment.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.020(1.13%) |
Mkt cap ! $153.5M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.81 | $1.78 | $49.59K | 27.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 100 | 1 |
View Market Depth
| Last trade - 15.41pm 26/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |